Search Result "tyrosine kinase inhibitors"


Review Article

Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: AComprehensive Review

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 13 Year: 2023 Page: 1464-1481
Author(s):

In silico Approaches to Tyrosine Kinase Inhibitors’ Development

Ebook: Marvels of Artificial and Computational Intelligence in Life Sciences

Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815136807123010014
Meta-Analysis

The Role of Tyrosine Kinase Inhibitors in Reduction of Mortality fromNon-small Cell Lung Cancer: A Meta-analysis

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 5 Year: 2023 Page: 928-937
Author(s):

Mini-Review Article

Trends of Receptor Tyrosine Kinase Researches Based on BibliometricAnalysis

Journal: Mini-Reviews in Organic Chemistry
Volume: 20 Issue: 3 Year: 2023 Page: 250-259
Author(s):

Review Article

Recent Advances in Structural Modification Strategies for Lead Optimizationof Tyrosine Kinase Inhibitors to Explore Novel AnticancerAgents

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 24 Year: 2023 Page: 2734-2761
Author(s):

Review Article

Recent Trends in Rationally Designed Molecules as Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 13 Year: 2023 Page: 1529-1567
Author(s): Kamal Dua,Dinesh K. Chellappan,Flavia Zacconi,Gaurav Gupta,Niraj Kumar Jha,Harish Dureja,Krishnan Anand,Sachin Kumar Singh,Yinghan Chan,Mousmee Sharma

Research Article

Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment ofLarge Hepatocellular Carcinoma

Journal: Current Cancer Drug Targets
Volume: 23 Issue: 7 Year: 2023 Page: 564-571
Author(s):

Review Article

Can Nanomedicinal Approaches Provide an Edge to the Efficacy ofTyrosine Kinase Inhibitors?

Journal: Current Medicinal Chemistry
Volume: 30 Issue: 13 Year: 2023 Page: 1482-1501
Author(s):

Review Article

Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 8 Year: 2023 Page: 900-921
Author(s): Md Shahid Ayaz,Ghanshyam Das Gupta

Perspective

First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor forthe Treatment of Patients with Myelofibrosis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1355-1360
Author(s): Surya K. De

Previous   Next

Go To   Results 1 - 1 of 273

Filter Result

Volume Year
Content Type
Ads
© 2023 Bentham Science Publishers | Privacy Policy